• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Postvaccination Immunogenicity of COVID-19 Vaccine in Pediatric Inflammatory Bowel Disease: Comment.

作者信息

Kleebayoon Amnuay, Wiwanitkit Viroj

机构信息

From Private Academic Consultant, Samraong, Cambodia.

Adjunct Professor, Chandigarh University, Punjab, India.

出版信息

J Pediatr Gastroenterol Nutr. 2023 Jun 1;76(6):e89-e90. doi: 10.1097/MPG.0000000000003761. Epub 2023 Mar 12.

DOI:10.1097/MPG.0000000000003761
PMID:36913710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10171094/
Abstract
摘要

相似文献

1
Postvaccination Immunogenicity of COVID-19 Vaccine in Pediatric Inflammatory Bowel Disease: Comment.新冠疫苗在儿童炎症性肠病中的接种后免疫原性：评论
J Pediatr Gastroenterol Nutr. 2023 Jun 1;76(6):e89-e90. doi: 10.1097/MPG.0000000000003761. Epub 2023 Mar 12.
2
Correspondence on "Immunogenicity of COVID-19 Vaccine Doses in Patients With Inflammatory Bowel Disease".关于“炎症性肠病患者中新冠疫苗剂量的免疫原性”的通信
Inflamm Bowel Dis. 2022 Oct 3;28(10):e142. doi: 10.1093/ibd/izac108.
3
Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination.COVID-19 疫苗接种后，接受抗 TNF 治疗的炎症性肠病患者的细胞介导免疫反应更高。
Inflamm Bowel Dis. 2023 Aug 1;29(8):1202-1209. doi: 10.1093/ibd/izac193.
4
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease.儿童炎症性肠病中SARS-CoV-2疫苗接种的体液免疫反应及安全性
Am J Gastroenterol. 2023 Jan 1;118(1):129-137. doi: 10.14309/ajg.0000000000002016. Epub 2022 Sep 16.
5
Attitudes towards COVID-19 vaccination in patients with inflammatory bowel disease.炎症性肠病患者对 COVID-19 疫苗接种的态度。
Intern Med J. 2022 Jun;52(6):1070-1074. doi: 10.1111/imj.15722. Epub 2022 May 18.
6
Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases.第三和第四剂疫苗可增强和延长免疫介导的炎症性疾病成年患者对 SARS-CoV-2 的免疫力。
J Immunol. 2023 Aug 1;211(3):351-364. doi: 10.4049/jimmunol.2300190.
7
Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study.免疫介导的炎症性疾病患者混合 COVID-19 疫苗方案的免疫原性和安全性：一项单中心前瞻性队列研究。
BMJ Open. 2023 May 30;13(5):e071397. doi: 10.1136/bmjopen-2022-071397.
8
Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapy.接受抗TNF治疗的炎症性肠病儿科患者对BNT162b2新冠病毒疫苗的抗体反应。
Gut. 2022 Sep;71(9):1922-1924. doi: 10.1136/gutjnl-2021-326196. Epub 2021 Nov 23.
9
Anti-tumor necrosis factor therapy is associated with attenuated humoral response to SARS-COV-2 vaccines in patients with inflammatory bowel disease.抗肿瘤坏死因子治疗与炎症性肠病患者对 SARS-CoV-2 疫苗的体液免疫应答减弱相关。
Vaccine. 2023 Jun 13;41(26):3862-3871. doi: 10.1016/j.vaccine.2023.05.012. Epub 2023 May 8.
10
Response to Letter to the Editor: Post-Vaccination Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine and Its Predictors in Pediatric Inflammatory Bowel Disease.
J Pediatr Gastroenterol Nutr. 2023 Jun 1;76(6):e90. doi: 10.1097/MPG.0000000000003760. Epub 2023 Mar 12.